CoVBio

Centivax

This company develops broad-spectrum vaccines and monoclonal antibodies using computational immune engineering to protect against infectious diseases and pathogens for global healthcare systems.

Vicebio

This biopharmaceutical company develops multivalent vaccines for respiratory viral infections targeting older adults and immunocompromised patients.

RQ Bio

RQ Bio develops long-acting monoclonal antibodies to provide seasonal influenza protection for vulnerable and immunocompromised patients who cannot rely on vaccination alone.

Aerium Therapeutics

This biopharmaceutical company develops monoclonal antibodies and antiviral treatments to protect immunocompromised patients against COVID-19 and future epidemic threats.

Invivyd

Invivyd develops monoclonal antibody therapies to protect immunocompromised patients from serious viral infectious diseases, including COVID-19 and measles.

Adagio tx

This biopharmaceutical company develops monoclonal antibody treatments and prophylactics for infectious viral diseases to protect patients against coronaviruses and their evolving variants.

Halo Therapeutics

This company develops small-molecule antiviral nasal sprays to treat respiratory viral infections for patients suffering from conditions like Covid-19.

KOBIOLABS

This company develops microbiome-derived therapeutics and live biotherapeutic products for patients with immune, metabolic, neurological and gastrointestinal diseases.